Clinical Trial Update: One-month Latent Tuberculosis Treatment for Renal Transplant Candidates [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating a one-month latent tuberculosis treatment regimen for patients with end-stage renal disease who are renal transplant ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Latent Tuberculosis Infection

Drugs mentioned

• Latent tuberculosis treatment

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Latent Tuberculosis, End Stage Renal Disease | Phase 4 | Status: ACTIVE_NOT_RECRUITING